Replies to post #32263 on Ariad Pharmaceuticals Inc fka ARIA

[DewDiligence]

The objectivity of Credit Suisse is in question here, being a Swiss Bank and Novartis being a Swiss pharma.

The objectivity of sell-side analysts is always in question, but not for the reason you posited, which is just plain silly.

[vidpok45]

Excellent post. Anything BUT silly.

[Jesspro]

This is the only way they could keep up with the rising tide of
ARIA. Every which way they look in oncology, there's pona news. Now,
that pona is affecting the proteins of neurological diseases, they
are getting so nervous that their dominance is getting seriously
threatened. Meanwhile, the ARIAD people just keep marching to the
drumbeat of good news about pona, 113, and their pipeline. Good
science always prevails whoever is holding it. What they're doing is an exercise in futility and desperation. CS credibility will now be tested in the next 12 months...jmho.

[Jesspro]

Great post 2da....

[binchey]

As a Belgian(Novartis is strong in my country unfortunately), I am very familiar with all the crap Novartis is good at(!) We can discuss hours and hours but I don't give a damn to them anyway.

These bullsh*t reports are not an issue anymore (at least for me)

WHY?

- they give me trading opportunities while waiting for our rocking results on EPIC and all other ongoing/obvious trials here and there. Time is on my side as a cool ARIAD investor.

- these attacks are harbingers of the rise of our planet's new oncology star -> ARIAD